Please use this identifier to cite or link to this item: http://dspace.dtu.ac.in:8080/jspui/handle/repository/17245
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDABODIYA, VIVEK-
dc.date.accessioned2019-12-31T06:30:25Z-
dc.date.available2019-12-31T06:30:25Z-
dc.date.issued2016-05-
dc.identifier.urihttp://dspace.dtu.ac.in:8080/jspui/handle/repository/17245-
dc.description.abstractThe Valuation report on Aarti Drugs LTD. is done keeping in mind a Value Equity philosophy, which is based on the belief that all successful investing should thoughtfully weigh two important attributes of a stock: price and prospects. Since some value managers tend to focus almost exclusively on stock price, they often underestimate the importance of prospects. However, we believe a company’s prospective ability to generate high cash flow returns on capital will strongly influence investment success. In our view, using a strong valuation discipline to purchase well-positioned, cash generating businesses run by shareholder-oriented management teams is the best formula for long-term portfolio performance.en_US
dc.language.isoen_USen_US
dc.relation.ispartofseriesTD-2213;-
dc.subjectDRUGS LTDen_US
dc.subjectCASH FLOWen_US
dc.subjectMARKETINGen_US
dc.titleAARTI DRUGS LTD. FINANCIAL ANALYSIS AND PROPOSED ACQUISITIONen_US
dc.typeThesisen_US
Appears in Collections:MBA

Files in This Item:
File Description SizeFormat 
VivekDabodiya final.pdf941.03 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.